Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mirtoselect Bilberry Extract is a **standardized extract of bilberry (Vaccinium myrtillus L.) fruit** clinically studied and characterized by a content of ≥36% anthocyanins (by HPLC), with ≤1% anthocyanidins. It is renowned for evidence-based benefits in vascular and retinal (eye) health, including improving contrast sensitivity and tear secretion, with additional indications for metabolic and cardiovascular health. Its mechanisms are attributed mainly to its anthocyanin profile, conferring potent antioxidant and microvascular-stabilizing effects. Clinical studies show improvement in antioxidant potential and support for eye conditions, especially dry eye, as well as possible benefits in memory and blood sugar support[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mirtoselect Bilberry Extract.